209 related articles for article (PubMed ID: 8757818)
1. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.
Salloway S; Mermel LA; Seamans M; Aspinall GO; Nam Shin JE; Kurjanczyk LA; Penner JL
Infect Immun; 1996 Aug; 64(8):2945-9. PubMed ID: 8757818
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
3. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
4. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
Ang CW; Laman JD; Willison HJ; Wagner ER; Endtz HP; De Klerk MA; Tio-Gillen AP; Van den Braak N; Jacobs BC; Van Doorn PA
Infect Immun; 2002 Mar; 70(3):1202-8. PubMed ID: 11854201
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
Prendergast MM; Lastovica AJ; Moran AP
Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
Yuki N; Miyatake T
Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits.
Ang CW; Noordzij PG; de Klerk MA; Endtz HP; van Doorn PA; Laman JD
Infect Immun; 2002 Sep; 70(9):5081-5. PubMed ID: 12183556
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.
Bowes T; Wagner ER; Boffey J; Nicholl D; Cochrane L; Benboubetra M; Conner J; Furukawa K; Furukawa K; Willison HJ
Infect Immun; 2002 Sep; 70(9):5008-18. PubMed ID: 12183547
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.
Goodyear CS; O'Hanlon GM; Plomp JJ; Wagner ER; Morrison I; Veitch J; Cochrane L; Bullens RW; Molenaar PC; Conner J; Willison HJ
J Clin Invest; 1999 Sep; 104(6):697-708. PubMed ID: 10491405
[TBL] [Abstract][Full Text] [Related]
10. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
Yuki N; Koga M; Hirata K
Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
[TBL] [Abstract][Full Text] [Related]
11. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
Godschalk PC; Kuijf ML; Li J; St Michael F; Ang CW; Jacobs BC; Karwaski MF; Brochu D; Moterassed A; Endtz HP; van Belkum A; Gilbert M
Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
[TBL] [Abstract][Full Text] [Related]
13. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
14. Diversity of lipopolysaccharide structures in Campylobacter jejuni.
Penner JL; Aspinall GO
J Infect Dis; 1997 Dec; 176 Suppl 2():S135-8. PubMed ID: 9396697
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome.
Neisser A; Bernheimer H; Berger T; Moran AP; Schwerer B
Infect Immun; 1997 Oct; 65(10):4038-42. PubMed ID: 9317004
[TBL] [Abstract][Full Text] [Related]
16. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain.
Shin JE; Ackloo S; Mainkar AS; Monteiro MA; Pang H; Penner JL; Aspinall GO
Carbohydr Res; 1997 Dec; 305(2):223-32. PubMed ID: 9581276
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure.
Aspinall GO; Fujimoto S; McDonald AG; Pang H; Kurjanczyk LA; Penner JL
Infect Immun; 1994 May; 62(5):2122-5. PubMed ID: 8168981
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of Guillain-Barré syndrome and Fisher's syndrome: molecular mimicry between antecedent infectious agents and components of nerve tissues].
Yuki N
Rinsho Shinkeigaku; 1995 Dec; 35(12):1373-5. PubMed ID: 8752400
[TBL] [Abstract][Full Text] [Related]
19. [Guillain-Barré syndrome].
Yuki N
Nihon Rinsho; 1994 Nov; 52(11):2952-8. PubMed ID: 7996693
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
